Nureca Ltd
Incorporated in 2016, Nureca Ltd is in the business of home healthcare and wellness products[1]
- Market Cap ₹ 276 Cr.
- Current Price ₹ 276
- High / Low ₹ 469 / 252
- Stock P/E 1,531
- Book Value ₹ 197
- Dividend Yield 0.00 %
- ROCE -6.38 %
- ROE -5.44 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Earnings include an other income of Rs.14.0 Cr.
- Promoter holding has decreased over last 3 years: -6.76%
- Working capital days have increased from 108 days to 152 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: E-Commerce/App based Aggregator Industry: Trading
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|
0.02 | 0.59 | 0.73 | 99.43 | 213.33 | 255.55 | 111.90 | 96.17 | |
0.02 | 0.57 | 0.70 | 89.72 | 151.65 | 199.78 | 127.30 | 106.36 | |
Operating Profit | 0.00 | 0.02 | 0.03 | 9.71 | 61.68 | 55.77 | -15.40 | -10.19 |
OPM % | 0.00% | 3.39% | 4.11% | 9.77% | 28.91% | 21.82% | -13.76% | -10.60% |
0.00 | 0.00 | 0.00 | 0.06 | 2.82 | 7.72 | 7.17 | 13.97 | |
Interest | 0.00 | 0.00 | 0.00 | 0.77 | 1.60 | 0.73 | 0.43 | 0.39 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.37 | 0.41 | 1.43 | 2.30 | 2.22 |
Profit before tax | 0.00 | 0.02 | 0.03 | 8.63 | 62.49 | 61.33 | -10.96 | 1.17 |
Tax % | 50.00% | 33.33% | 25.72% | 25.54% | 26.12% | 23.18% | ||
0.00 | 0.02 | 0.02 | 6.41 | 46.53 | 45.31 | -8.42 | 0.18 | |
EPS in Rs | 0.00 | 20.00 | 20.00 | 6,410.00 | 46.53 | 45.31 | -8.42 | 0.18 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 4.30% | 6.62% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 185% |
3 Years: | 4% |
TTM: | -27% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 102% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -38% |
1 Year: | -17% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 17% |
Last Year: | -5% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.01 | 0.01 | 10.00 | 10.00 | 10.00 | 10.00 |
Reserves | 0.00 | 0.02 | 0.04 | 14.96 | 153.29 | 193.74 | 185.26 | 187.13 |
0.00 | 0.00 | 0.00 | 9.70 | 3.81 | 4.33 | 3.25 | 2.68 | |
0.07 | 0.31 | 1.23 | 9.19 | 18.79 | 11.47 | 8.18 | 7.89 | |
Total Liabilities | 0.08 | 0.34 | 1.28 | 33.86 | 185.89 | 219.54 | 206.69 | 207.70 |
0.00 | 0.00 | 0.06 | 1.06 | 3.37 | 9.78 | 8.08 | 6.96 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 0.42 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.05 | 0.82 | 34.49 | 62.14 | 3.06 |
0.08 | 0.34 | 1.22 | 32.75 | 181.40 | 174.85 | 136.47 | 197.68 | |
Total Assets | 0.08 | 0.34 | 1.28 | 33.86 | 185.89 | 219.54 | 206.69 | 207.70 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
-0.01 | -7.85 | 35.10 | 1.83 | 12.05 | |||
0.00 | -0.39 | -110.48 | -3.37 | -18.30 | |||
0.01 | 8.20 | 92.34 | -7.30 | -1.51 | |||
Net Cash Flow | 0.00 | -0.05 | 16.96 | -8.84 | -7.76 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
Debtor Days | 365.00 | 86.61 | 65.00 | 47.35 | 0.39 | 4.10 | 13.93 |
Inventory Days | 0.00 | 100.96 | 589.62 | 92.82 | 135.10 | 173.87 | 154.02 |
Days Payable | 232.98 | 849.33 | 33.05 | 32.18 | 12.94 | 23.36 | |
Cash Conversion Cycle | 365.00 | -45.41 | -194.71 | 107.12 | 103.31 | 165.03 | 144.59 |
Working Capital Days | 182.50 | -12.37 | -45.00 | 85.13 | 61.58 | 110.39 | 152.20 |
ROCE % | 100.00% | 75.00% | 76.05% | 66.84% | 32.74% | -6.38% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 2d
- Compliance Under Regulation 40(10) Of The Securities Exchange Board Of India (LODR) Regulations, 2015 10 Apr
- Compliance Certificate - Regulation 7 (3) Of SEBI (LODR) Regulations, 2015. 9 Apr
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2 Apr - Press Release titled " Nureca Limited''s Dr Trust Recognized as a ''Well Known Trademark'' by the Indian Trademark Registry"
- Closure of Trading Window 27 Mar
Business Overview:[1][2]
NL is a D2C healthcare and wellness company with a USFDA, CE, FSSAI, and ISO 13485-certified product range of over 150 SKUs across different categories. It supports diagnosis, treatment, and prevention of illness through monitoring & analysis of health data.